HMS
RGNX icon

Hanseatic Management Services’s Regenxbio RGNX Stock Holding History

Hanseatic Management Services’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,229
Closed -$168K – 337
2018
Q3 		$168K Buy
2,229
+2,210
+11,632% +$159K 0.16% 126
2018
Q2 		$1K Buy
+19
New +$907 ﹤0.01% 362

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hanseatic Management Services's RGNX Position: Q4 2018 in Review

Hanseatic Management Services sold out of Regenxbio (RGNX) in Q4 2018, closing a stake of 2,229 shares — an estimated $168K sold.

Hanseatic Management Services first reported a position in RGNX in Q2 2018 and held it in 2 quarters. The position peaked at $168K in Q3 2018. 183 funds tracked by Wall St. Rank hold RGNX as of Q4 2018.

  • Hanseatic Management Services reported no remaining Regenxbio position as of Q4 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 2,229 Regenxbio shares in Q4 2018, an estimated $168K.
  • Hanseatic Management Services first reported a position in Regenxbio in Q2 2018 and held it in 2 quarters.
  • Hanseatic Management Services's Regenxbio position peaked at $168K in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Regenxbio as of Q4 2018.

Based on Hanseatic Management Services's 13F filing for Q4 2018, filed 29 Jan 2019.